Here are relevant reports on : respiratory-drugs-market
-
COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025
The COVID-19 vaccines & drugs market is expected to grow from USD 2,273 million in 2022 to USD 1,401 million by 2025 at a compound annual growth rate (CAGR) of 14.9% during the forecast period.Key players in the COVID-19 vaccines market include Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium) among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031
The Asia Pacific respiratory care devices market is projected to reach USD 8.76 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Medical PPE Market by Product Type (Protective Clothing, Respiratory, Hand Protection), End-use Industry (Hospitals, Outpatient/Primary Care Facilities), and Region - Global Forecast to 2030
The medical PPE market is projected to reach USD 28.8 billion by 2030, at a CAGR of 4.4% from USD 20.4 billion in 2022. The rising product demand, especially from the healthcare industry, due to the global Covid-19 pandemic, coupled with rising awareness about Healthcare-Associated Infections (HAIs), is likely to drive the market growth. Personal Protective Equipment (PPE) acts as a barrier between infectious viruses and the eyes, nose, mouth, and skin of the person using it. Thus, healthcare personnel use PPE to minimize their exposure to infectious microorganisms in the clinical environment. Products, such as gowns and gloves, are used to interrupt the transmission of pathogens when treating patients with communicable diseases.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Capnography Equipment Market by Product (Multiparameter, Standalone, Software, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User (Hospitals, ASC), Region - Global Forecast to 2030
The capnography equipment market, valued at US$0.51 billion in 2024, stood at US$0.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2024 to 2030, culminating in a forecasted valuation of US$0.67 billion by the end of the period. The capnography equipment market is expanding due to the increasing prevalence of respiratory and cardiovascular disorders, a rise in surgical procedures, and a greater focus on patient safety through continuous monitoring.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
ECMO Machines Market by Product [ECMO Machines, Components (Oxygenators, Pumps, Controllers)], Modality (Venovenous and Arteriovenous ECMO), Patient Type (Adults, Neonates), Application (Respiratory, Cardiac), End User (Hospitals) - Global Forecast to 2030
The global ECMO machine market, valued at US$0.62 billion in 2024, stood at US$0.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2030, culminating in a forecasted valuation of US$0.86 billion by the end of the period. The ECMO machines market is primarily driven by the increasing prevalence of cardiovascular and respiratory diseases, growing adoption of ECMO in lung transplantation procedures, growth in the number of ECMO centers, and technological advancements.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030
The global blood gas analyzer market, valued at US$2.61 billion in 2024, stood at US$2.70 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2024 to 2030, culminating in a forecasted valuation of US$3.38 billion by the end of the period. Growth is being driven by the rising prevalence of chronic and acute diseases, increasing demand for rapid and accurate diagnostics, and continuous advancements in blood gas analyzer technology.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031
The North America Respiratory Care Device market, valued at US$9.88 billion in 2025, stood at US$10.53 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$15.31 billion by the end of the period. The North America respiratory care devices market has been growing as the number of chronic respiratory diseases, such as COPD, asthma, and sleep apnea, continues to rise.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Catheter Stabilization Devices Market by Product ((Arterial, CVS (Portal, Femoral), Chest, Epidural, Peripheral (Nasogastric, Endotracheal, Foley)), Application (Cardiovascular, Respiratory), End User - Global Forecasts to 2025
The global catheter stabilization devices market growth is primed to transition from $1.18 billion in 2020 to $1.90 billion by 2025, showcasing a strong CAGR of 10.0%. The emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of heart and other life style diseases.
- Published: June 2020
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
